Management ChangeApr 7, 2026, 06:06 AM
Protagenic Therapeutics CFO Alexander Arrow to be Terminated
AI Summary
Protagenic Therapeutics, Inc. announced that its Chief Financial Officer, Alexander Arrow, MD, will be terminated effective April 30, 2026. The departure of a key executive can create uncertainty and potentially impact investor confidence.
Key Highlights
- Alexander Arrow, MD, CFO of Protagenic Therapeutics, will be terminated.
- Termination is effective April 30, 2026.
- The announcement was made by the Board of Directors on March 31, 2026.
Price Impact